Cristina Daniele has a scientific background in regenerative medicine and conducted her PhD research on ABCB5-positive stem cells. She has been with RHEACELL GmbH & Co. KG for more than six years, where she leads the clinical development and execution of clinical trials for advanced cell therapies, with a focus on Epidermolysis Bullosa.